NCT06232577View on ClinicalTrials.gov

5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

March 27, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Intra-abdominal Cancer
Interventions
DRUG

Hydrocodone

Given by PO

DRUG

Tramadol

Given by PO

DRUG

Oxycodone

Given by PO

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT06232577 - 5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial | Biotech Hunter | Biotech Hunter